Given that HFD-induced obesity and IL-6Rα deficiency both increase hepatic Lepr expression suggests that obese animals would profit even more from genetic IL-6Rα and hepatic Lepr deficiency in the DEN-induced HCC protocol. The gene discussed is IL6R; the disease is hepatocellular carcinoma.